According to filings with the U.S. Securities and Exchange Commission, Empirical Spine is raising $10,349,337.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Richard Treadwell played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Empirical Spine
Empirical Spine, Inc., is focused on developing disruptive solutions for the surgical treatment of spinal disorders, in order to deliver superior clinical outcomes while lowering overall healthcare costs. We are building a new standard in spine surgery that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life by creating a new category called Dynamic Sagittal TetherTM (DST). For patients with mobile degenerative spondylolisthesis, LimiFlexTM is the first and only Dynamic Sagittal Tether that restores the natural motion and stability required after a decompression by augmenting the posterior tension band, creating elastic resistance to flexion and maintaining lordosis, and offers the potential for significant reduction in cost, invasiveness, and sequelae compared to spinal fusion. The U.S. pivotal trial on our breakthrough LimiFlex Dynamic Sagittal Tether is fully enrolled and nearing its two-year endpoint. In summer 2022, we expect to submit results from this trial to the FDA for PMA approval.

To learn more about Empirical Spine, visit http://limiflex.com/

Contact:
Richard Treadwell, President and Chief Executive Officer
650-721-7616
https://www.linkedin.com/in/richardtreadwell/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.